1. Home
  2. People
  3. Shweiky, Ramy

Ramy Shweiky

Partner

San Francisco

Ramy Shweiky is a corporate Partner in the San Francisco office and strategic advisor to companies in the technology and life sciences sectors.

Ramy advises public and private companies and their financial sponsors in the technology and life sciences sectors on complex, strategic transactions, including cross-border M&A, joint ventures, and multi-jurisdictional carve-outs. He also counsels boards and investors on fiduciary duties and other corporate governance matters.

Ramy is a member of the board of directors of Crisis Text Line, a global not-for-profit organization providing free mental health texting service. He has been recognized as a "Rising Star" in M&A by Super Lawyers.

  • Select Transactions

    • Workday in connection with multiple transactions, including its $700 million acquisition of Peakon ApS and its acquisition of Zimit.
    • FormFactor in connection with its $100 million divestment of FRT metrology.
    • Bayer AG in connection with multiple transactions, including: the divestment of Bayer's West Sacramento biologics R&D site to Ginkgo Bioworks and related multi-year strategic partnership with Ginkgo Bioworks to accelerate R&D of biologics projects for agriculture; the sale of its global vegetable seeds business to BASF (announced deal value $1.19 billion); the formation of its BlueRock Therapeutics joint venture with Versant Ventures and subsequent acquisition of BlueRock Therapeutics (announced enterprise value $1 billion); its $215 million investment in Century Therapeutics, LLC; its cumulative investment of over $50 million in One Drop as lead investor in One Drop's Series B and Series C financings; its Unfold Bio joint venture with Temasek; its Joyn Bio joint venture with Ginkgo Bioworks; its Oerth Bio joint venture with Arvinas and related investment in Arvinas; its investment in the US$45 million Series C financing of Sound Agriculture; and several other strategic investments of Leaps by Bayer in an array of emerging growth life science companies.
    • Trimble Navigation in connection with its global divestment of four businesses to The Jordan Company and its acquisition of several software companies, including: Bilberry, Azteca Systems LLC (dba “Cityworks”); Vianova Systems AS; Nexala Ltd.; Manhattan Software Group Ltd.; and certain other confidential non-public transactions.
    • Marvell Technology in connection with multiple transactions, including its acquisition of Tanzanite Silicon Solutions.
    • Zynga in its $250 million acquisition of Chartboost.
    • Luminar Technologies in connection with its acquisitions of Freedom Photonics and Civil Maps.
    • Maxim Integrated Products in its acquisitions of Trinamic Motion Control BmBH and Icron Technologies; the sale of its MEMs business to Hanking Industrial; the sale/outsourcing of its manufacturing facility in San Antonio to TowerJazz; the sale of its smart meter/energy monitoring business to Silergy; the sale of its capacitive touch business to Qualcomm; and several other confidential non-public transactions.
    • Motorola Solutions in the sale of its Enterprise Mobility business to Zebra Technologies (announced deal value US$3.45 billion) (international aspects only) and certain other confidential non-public transactions.
    • Agilent Technologies in its spinoff of its electronic measurement business (known as Keysight Technologies).
    • NetScout Systems in connection with its acquisition of Danaher’s communication business (announced deal value US$2.6 billion) (international aspects only).
    • Symantec Corporation in the sale of its information management business (dba “Veritas”) to The Carlyle Group (announced deal value US$8 billion) (international aspects only).
    • Essex Property Trust in numerous registered and Rule 144A equity and debt offerings.

News